Related Experiment Video
Updated: Jul 11, 2025
06:08
Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
Published on: January 7, 2019
9.2K
Psilocybin and Other Classic Psychedelics in Depression
D J Nutt1, J M Peill2, B Weiss2
1Centres for Neuropsychopharmacology & Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK. d.nutt@imperial.ac.uk.
Current Topics in Behavioral Neurosciences
|November 13, 2023
Summary
Psychedelic compounds, like psilocybin, show promise for treating depression by inducing profound psychological experiences and altering brain activity. These effects, when combined with therapy, offer rapid and sustained mood improvement, distinct from traditional antidepressants.
Area of Science:
- Neuroscience
- Psychopharmacology
- Clinical Psychology
Background:
- Psychedelic drugs are re-emerging in clinical research for various disorders, notably depression.
- Specific psychedelics targeting the 5-HT2A receptor, such as psilocybin and DMT, induce unique psychological effects.
Purpose of the Study:
- To summarize scientific studies on psychedelic use in depressed individuals.
- To highlight clinical, psychological, and neuroimaging features contributing to therapeutic effects.
Main Methods:
- Review of scientific literature on psychedelic interventions for depression.
- Analysis of clinical, psychological, and neuroimaging data from studies.
Main Results:
- Psychedelics coupled with psychological support yield rapid, long-lasting mood improvement in depression.
- Therapeutic effects may stem from increased brain entropy, enhanced cognitive flexibility, and altered self-referential processing.
Conclusions:
- Serotonergic psychedelics offer a novel therapeutic avenue for depression.
- The brain mechanisms of psychedelics may differ from traditional antidepressants.
Related Concept Videos
01:27Hallucinogens and Psychedelics
179
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
179
01:23Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
01:22CNS Stimulants: Psychedelic Agents
158
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
158
01:27Depressive Disorders: Etiology
104
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
104
01:25Cognitive Therapy
154
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
154
01:30Electroconvulsive Therapy
47
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
47